England's NHS will add chickenpox vaccination to its routine childhood immunization schedule starting January 2, 2026. The move expands the standard vaccination programme to protect children against the highly contagious viral infection.
Chickenpox spreads through respiratory droplets or direct contact with the characteristic fluid-filled blisters. Most people recover within one to two weeks, but complications can include bacterial infections, pneumonia, and encephalitis, particularly in infants, pregnant women, and immunocompromised individuals. The virus also reactivates later in life as shingles, causing painful nerve inflammation.
The vaccine offers protection against initial infection and reduces severity if breakthrough cases occur. Children typically receive two doses spaced several weeks apart for optimal immunity. The vaccination programme targets infants and young children, aligning with other routine childhood jabs.
This marks a significant change to England's immunization strategy. Previously, the NHS only offered chickenpox vaccination to healthcare workers and immunocompromised patients. The expansion reflects evolving evidence on the vaccine's effectiveness and the public-health burden of chickenpox, which affects thousands of children annually in the UK.